Go to the list of all blogs
Anna G's Avatar
published in Blogs
Sep 16, 2023
📈Akoustis Technologies (AKTS): Volume Soars with +244% 5-Day Streak! What’s Behind the Surge?🚀

📈Akoustis Technologies (AKTS): Volume Soars with +244% 5-Day Streak! What’s Behind the Surge?🚀

🚀 Ready to Dive into AI-Powered Trading? Discover the Top 10 AI Robots! 📊

 if you're interested in AI trading and want to explore the top 10 AI robots, you can find them at the following links:

  1. Top 10 AI Robots  - SORT BY Sharper 
  2. Top 10 AI Robots  - SORT BY  30-day Annualized Return
  3. Top 10 AI Robots  - SORT BY  All Time Annualized Return

These AI robots are designed to provide insights and strategies to enhance your trading experience. Feel free to explore them and discover how AI can empower your trading decisions. 🤖📈

Akoustis Technologies

$AKTS has been making waves in the stock market lately, especially with its notable volume surge. Over the past five consecutive days, AKTS has seen an impressive average daily volume gain of 244%. Despite the broader Telecommunications Equipment industry trending downwards, this stock has drawn considerable attention from investors and traders alike.

📊Volume vs. Price Dynamics

The stock's volume momentum contrasts with its recent price performance. AKTS experienced a price decline of -39.05%, settling at $0.92. Such a divergence between volume and price could suggest a potential trend reversal, making it an enticing buy signal for some investors. Historical data seems to support this bullish view: A.I.dvisor's analysis of 48 similar volume-price patterns in the past found that 39 (or 81%) were followed by positive price movements.

🔢Earnings Report

However, it’s crucial to factor in the company’s recent earnings report from September 06. AKTS reported an earnings per share (EPS) of -20 cents, falling short of the estimated -16 cents. The firm’s current market capitalization stands at 75.25M, backed by 2.41M shares outstanding.

🌐Industry Overview

AKTS is nestled within the Telecommunications Equipment industry, which has been grappling with an average weekly price decline of -1%. This industry is responsible for producing a myriad of critical communications equipment, from fiber optic products to satellite systems. Titans in this space include Cisco Systems, Nokia Corp, and Apple Inc., amongst others.

💹Market Capitalization Insights

The Telecommunications Equipment Industry has a broad market cap spectrum, ranging from a meager 1.59K to a whopping 229.87B. Unsurprisingly, Cisco Systems (CSCO) claims the throne with the highest valuation, whereas ABILF stands at the other end of the spectrum.

📉Recent Performance

The last five trading days for AKTS weren't too rosy, with the stock shedding -16.34%. This was accompanied by a trade volume of approximately 285,696 shares daily. A significant drawdown of -36.05% was observed during this period.

While Akoustis Technologies has experienced a dip in its stock price, the explosive volume could hint at a turning point. As always, investors should conduct their due diligence and factor in both the micro and macroeconomic elements before making investment decisions.

Join us next week as we dive deeper into the intricacies of the Telecommunications Equipment industry and explore potential hidden gems!

Related Ticker: AKTS

AKTS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for AKTS turned positive on August 10, 2026. Looking at past instances where AKTS's MACD turned positive, the stock continued to rise in of 32 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 24, 2026. You may want to consider a long position or call options on AKTS as a result. In of 64 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AKTS moved above its 50-day moving average on August 24, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AKTS crossed bullishly above the 50-day moving average on September 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKTS advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 76 cases where AKTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AKTS broke above its upper Bollinger Band on August 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AKTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.064) is normal, around the industry mean (20.457). P/E Ratio (0.000) is within average values for comparable stocks, (27.656). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.558). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (147.059) is also within normal values, averaging (443.914).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.34B. The market cap for tickers in the group ranges from 58 to 141.42B. VRTX holds the highest valuation in this group at 141.42B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 2,477%. QNRX experienced the highest price growth at 64%, while VBIO experienced the biggest fall at -96%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -13%. For the same stocks of the Industry, the average monthly volume growth was -22% and the average quarterly volume growth was 6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 79
Price Growth Rating: 53
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
AKTS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of filter products for radio frequency front-ends for mobile wireless devices

Industry Biotechnology

Profile
Details
Industry
Telecommunications Equipment
Address
17 Drydock Avenue
Phone
+1 617 461-4023
Employees
75
Web
https://www.aktisoncology.com
Interact to see
Advertisement
WES is an oil & gas midstream partnership (NYSE: WES) with largely fee‑based, long‑term volume contracts in key basins such as the Delaware and DJ, which insulate cash flows from direct oil price swings but still tie them to producer activity and throughput. Current positioning: The units trade around 41–42 dollars with a high cash yield (roughly 9% dividend), solid profitability (P/E about 14), and strong returns on equity above 40%, signaling a mature, cash‑generative infrastructure asset.
SD is a pure‑play upstream energy company with operations concentrated in U.S. onshore oil and gas, so its revenues are directly influenced by global oil and gas price movements.
TTI is an oilfield services and specialty chemicals company, not a direct oil producer, so it tends to benefit when higher oil prices lead to sustained drilling and completion activity rather than from price moves alone. The Iran war raises the odds of major supply disruptions, and several commentators see a path to Brent near 100 dollars per barrel if the Strait of Hormuz is impaired, which would support energy capex and, by extension, demand for TTI’s services and fluids.
COP is a global upstream heavyweight, producing more than 2.3 million barrels of oil equivalent per day and generating over 60 billion dollars in annual revenue, with a strategy centered on disciplined capex and robust cash returns to shareholders. The Iran war introduces a structural risk premium into oil markets; if supply from the region or traffic through Hormuz is disrupted, analysts see Brent potentially trading nearer 90–100 dollars per barrel or higher, which is supportive for ConocoPhillips’ cash flows and valuation.
ONEOK is a diversified midstream operator focused on gathering, processing, fractionation, transportation, storage, and marine export of natural gas, NGLs, refined products, and crude, with most revenue coming from relatively stable fee‑based contracts. The US–Iran war increases the odds of supply disruptions or perceived risks in the Gulf, which has already contributed to higher oil and LNG prices and a persistent geopolitical risk premium.
Exxon Mobil is a global energy giant with roughly 324 billion dollars in trailing revenue, around 29 billion dollars in earnings, record production near 4.7 million barrels per day, and a long runway of projects in Guyana, the Permian, LNG and carbon capture. The Iran war has disrupted shipping through the Strait of Hormuz and could keep a 10–20 dollar‑per‑barrel risk premium in crude if tensions stay high, which would generally be positive for XOM’s upstream earnings and refining margins.
Chevron is a global integrated oil and gas major with growing production, a strong balance sheet, and significant exposure to long‑life projects in the Permian, LNG, and Venezuela, aiming for structurally higher cash flows through 2026 and beyond. The Iran war has increased the probability of supply disruptions or perceived risk in the Gulf, and several analysts warn that Brent could move above 100 dollars per barrel if Hormuz traffic is impaired, which would generally be supportive for Chevron’s earnings and free cash flow.
Shell is a diversified global major with roughly 266.9 billion dollars in trailing revenue, 17.8 billion dollars in earnings, a 3.5% dividend yield, and an active buyback program, trading at about 13 times earnings near its 52‑week high. The Iran war materially raises the risk of disruptions or perceived threats around the Strait of Hormuz, which could push oil well above 80–100 dollars per barrel and tighten LNG markets, a setup that is generally supportive for Shell’s upstream and LNG businesses.
LMT is a defense heavyweight with roughly 75 billion dollars in annual revenue, about 5 billion dollars in earnings, and a backlog above 190 billion dollars spanning fighters, missiles, space, and sustainment contracts that support long‑term cash flow. The U.S.–Iran war has triggered a classic “flight to defense,” with sector ETFs and names like Lockheed rallying as investors price in higher defense spending, missile restocking, and elevated geopolitical risk for years to come.
NOC is a defense heavyweight with about 42 billion dollars in annual revenue, 4.18 billion dollars in earnings, and key growth programs in the B‑21 bomber, Sentinel ICBM, missile defense, and space, which are all strategically prioritized in U.S. and allied budgets. The Iran war has reinforced a rotation into defense stocks as investors expect elevated military spending, ammunition and missile restocking, and sustained demand for advanced systems, and commentary specifically cites Northrop as a likely beneficiary.
RTX is a broad aerospace and defense leader with about 88.6 billion dollars in 2025 revenue, 6.73 billion dollars in earnings, and a 268 billion dollar backlog spanning commercial and defense programs that support multi‑year growth. Management guides to 92–93 billion dollars in 2026 sales, adjusted EPS of 6.60–6.80, and free cash flow of 8.25–8.75 billion dollars, with analysts expecting roughly 6% EPS growth to around 6.67 dollars in 2026.
Delta is the most profitable major U.S. airline, with 2025 operating revenue of 58.3 billion dollars, adjusted EPS of 5.82 dollars, 12% ROIC, and manageable leverage, and it is guiding to 2026 EPS of 6.50–7.50 dollars and 3–4 billion dollars of free cash flow. The Iran war is pushing oil and jet fuel prices higher, with jet fuel benchmarks up about 22% this year amid fears over flows through the Strait of Hormuz, and long‑haul routes across the region are being rerouted, raising costs and causing disruptions.
GD produces business jets, combat vehicles, IT and mission systems, and submarines, with 2025 revenue of 52.55 billion dollars, net income of 4.21 billion dollars, EPS of 15.45, and a sizable backlog near 118 billion dollars that underpins future growth.​ The Iran war has boosted interest in defense stocks; sector ETFs are up double digits this year and analysts emphasize that long‑duration maintenance and modernization contracts can support cash flows even after the conflict cools.
HII is the dominant U.S. Navy shipbuilder, focused on aircraft carriers, submarines, and other major naval vessels, with about 12.0 billion dollars in trailing revenue, 569 million dollars in net income, and EPS of 14.50. The Iran war and threats around the Strait of Hormuz highlight the importance of naval and missile-defense capabilities; reports show interceptor stocks being depleted and stress that keeping sea lanes open will likely require sustained naval investment where HII is a key contractor.
United is a large global carrier with a premium‑focused “United Next” strategy that upgauges to larger, more fuel‑efficient aircraft and adds premium seats to improve margins over the next several years. The Iran war has forced widespread Middle East airspace closures, creating thousands of cancellations, diversions, longer flight times, and higher fuel burn; analysts warn of higher fares and air‑freight rates if the conflict persists.
GE Aerospace is a focused aviation and defense company with two major segments—commercial engines and services, and defense and propulsion—earning most of its profits from long‑duration engine service on an installed base near 80,000 engines. Revenue and earnings growth have been strong, with recent quarterly revenue above 11 billion dollars, up high‑teens year over year, and net income over 2 billion dollars; management guides to 2026 EPS of 7.10–7.40 dollars, well above this year’s roughly 5.4‑dollar consensus.
Shares of Citigroup (C) declined approximately 5.17% in the most recent completed trading session, closing at $110.19 versus a prior close of $116.19. The primary catalyst was hotter-than-expected U.S. Producer Price Index (PPI) data, stoking fears of persistent inflation and a reduced likelihood of near-term Federal Reserve rate cuts.
AVAV surged +16.83% in Monday's session, trading at $294.70 compared to Friday's closing price of $252.25 — a gain of $42.45 per share. The primary catalyst was a powerful confluence of geopolitical demand and corporate developments: the escalating U.S.-Iran military conflict dramatically amplified investor focus on AeroVironment's loitering munitions portfolio.
Shares of Venture Global surged approximately +16.61% on March 2, 2026, closing at $11.30 compared to the prior close of $9.69. The primary catalyst was a stronger-than-expected Q4 2025 earnings report, with GAAP EPS of $0.41 beating the consensus estimate of $0.36 by $0.05.
Shares of CCL plunged 10.11% in Monday's session, falling from a prior close of $31.55 to $28.36. The primary catalyst was a coordinated U.S. and Israeli military strike on Iran over the weekend, causing crude oil prices to surge approximately 8–9% and triggering a global risk-off selloff.